Suppr超能文献

尽管“没有疾病活动的证据”,但 RRMS 患者仍会出现脑微观结构损伤。

Brain microstructural injury occurs in patients with RRMS despite 'no evidence of disease activity'.

机构信息

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Department of Neurology, Lenox Hill Hospital, New York, USA.

出版信息

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):977-982. doi: 10.1136/jnnp-2017-317606. Epub 2018 Mar 16.

Abstract

OBJECTIVES

The accuracy of 'no evidence of disease activity' (NEDA) in predicting long-term clinical outcome in patients with relapsing remitting multiple sclerosis (RRMS) is unproven, and there is growing evidence that NEDA does not rule out disease worsening. We used diffusion tensor imaging (DTI) to investigate whether ongoing brain microstructural injury occurs in patients with RRMS meeting NEDA criteria.

METHODS

We performed a retrospective study to identify patients with RRMS visiting our centre over a 3-month period who had undergone prior longitudinal DTI evaluation at our facility spanning ≥2 years. Patients meeting NEDA criteria throughout the evaluation period were included in the NEDA group, and those not meeting NEDA criteria were included in an 'evidence of disease activity' (EDA) group. Fractional anisotropy (FA) and mean diffusivity (MD) maps were created, and annual rates of change were calculated.

RESULTS

We enrolled 85 patients, 39 meeting NEDA criteria. Both NEDA and EDA groups showed longitudinal DTI worsening. Yearly FA decrease was lower in the NEDA group (0.5%, p<0.0001) than in the EDA group (1.2%, p=0.003), while yearly MD increase was similar in both groups (0.8% for NEDA and EDA, both p<0.01). There was no statistical difference in deterioration within and outside of T2 lesions. DTI parameters correlated with disability scores and fatigue complaints.

CONCLUSIONS

White matter microstructural deterioration occurs in patients with RRMS over short-term follow-up in patients with NEDA, providing further evidence of the limitations of conventional measures and arguing for DTI in monitoring of the disease process.

摘要

目的

活动疾病不证据(NEDA)在预测复发缓解型多发性硬化症(RRMS)患者长期临床结局中的准确性尚未得到证实,并且越来越多的证据表明 NEDA 并不能排除疾病恶化。我们使用弥散张量成像(DTI)来研究符合 NEDA 标准的 RRMS 患者是否存在持续的脑微观结构损伤。

方法

我们进行了一项回顾性研究,以确定在我们中心就诊的 RRMS 患者,这些患者在我们中心进行了≥2 年的前瞻性 DTI 评估。在整个评估期间符合 NEDA 标准的患者被纳入 NEDA 组,不符合 NEDA 标准的患者被纳入“疾病活动证据”(EDA)组。创建了各向异性分数(FA)和平均弥散度(MD)图,并计算了每年的变化率。

结果

我们共纳入 85 例患者,其中 39 例符合 NEDA 标准。NEDA 和 EDA 组均表现出纵向 DTI 恶化。NEDA 组的 FA 每年下降率较低(0.5%,p<0.0001),而 EDA 组的 FA 每年下降率较高(1.2%,p=0.003),而两组的 MD 每年增加率相似(NEDA 组为 0.8%,EDA 组为 0.8%,两者均 p<0.01)。T2 病变内和病变外的恶化无统计学差异。DTI 参数与残疾评分和疲劳主诉相关。

结论

在符合 NEDA 的 RRMS 患者中,在短期随访中会出现白质微观结构恶化,这进一步证明了常规测量方法的局限性,并支持 DTI 在监测疾病过程中的应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验